Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Therapy for Advanced Hodgkin’s Disease

  • 12 Accesses

This is a preview of subscription content, log in to check access.


  1. 1.

    DeVita VT Jr : The consequences of the chemotherapy of Hodgkin disease; the 10th David A Karnofsky Memorial lecure. Cancer 47:_, 1981

  2. 2.

    Glodin A, Venditi JM, Humphreys SR, Mantel N: Quantitative evaluation of chemotherapeutic agents against advanced leukemia in mice. J Natl Cancer Inst 21 : 495, 1958

  3. 3.

    Skip er HE, Sehabel FM Jr, Wilcox WS: Experimental evaluation Of potential anticancer agents XIII. On the criteria and kinetics associated with ‘CurabIlity’ of experimental leukemia. Cancer Chemother Rep 35 : 3, 1964

  4. 4.

    Bruce WR, Meeker RE, Powers WE, Valeriote FA: Comparison of the dose and time survival Curves for normal hematopoietic and lymphoma colony forming cells exposed to vinblastine, vineristine arabinosyl cytosine and amethopterin. J Natl Cancer Inst 42 : 1015, 1969

  5. 5.

    DeVita VT Jr., Simon RM, Hubbard SM, et al: Curability of advanced Hodgkin’s disease with chemotherapy : Long term follow up of MOPP-treated patients at the National Cancer Institute. Ann Intern Med 92 : 587, 1980

  6. 6.

    Bonadonna G, Zucali R, Manfardini S, Delena M, Uslcnghi C: Combination Chemotherapy of Hodgkin’s disease with adriamycin, bleomycin, vinblastine and imidazole carboxamide versus MOPP. Cancer 36: 252 1975

  7. 7.

    Santoro A, Bonfante V, Bonadonna G: Salvage Chemotherapy with ABVD in MOPP resistant Hodgkin’s disease. Ann Intern Med 96: 139, 1982

  8. 8.

    Santoro A, Bonydonna G, Bonfante V, Valagussa P: Alternating drug combinations in the treatment of advanced Hodgkin’s disease. N Engl J Med 306 : 770, 1982

  9. 9.

    Coltman CA Jr: Chemotherapy of advanced Hodgkin disease. Seminar Oncol 7:155, 1980

  10. 10.

    Goldie J H, Coldman AJ: A mathematical model for relating the drug sensitivity of tumors to their spontaneous mutation rate. Cancer Treat Rep 63 : 1727, 1979

  11. 11.

    Wiernik PH, Longo D, Duffey PL et al: MOPP vs MOPP alternating with streptozotocin, CCNU, adriamycin and bluomy- cin (SCAB) for advanced Hodgkin’s disease. Proc Am Assoc Cancer Res 22 : 159, 1981

Download references

Author information

Correspondence to V. P. Choudhry.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Choudhry, V.P. Therapy for Advanced Hodgkin’s Disease. Indian J Pediatr 49, 823–825 (1982).

Download citation


  • Vinblastine
  • CCNU
  • Neonatal Jaundice
  • Monthly Cycle
  • Arabinosyl